Join the club for FREE to access the whole archive and other member benefits.

Taking the new path in the field of senolytics - SENISCA

29-Jul-2020

Key points from article :

SENISCA is a start-up company aiming to develop “senotherapeutic interventions”.

Found a new molecular pathway to create a new generation of senotherapeutic drugs.

Works by switching off the genes that control RNA splicing factors.

This turns on RNA splicing regulation to bring cells out of senescence and rejuvenates them.

Focused on tropical treatments for skin ageing and treatment for target diseases.

University of Exeter spinout SENISCA is currently raising a seed round of £950,000.

Old cells will be more young and beautiful

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Academic

Professor of Molecular Genetics at the University of Exeter.

Company

University of Exeter spinout aiming to develop senotherapeutic interventions

Academia

UK university and member of the Russell Group of leading research-intensive UK universities